🇺🇸 FDA
Pipeline program

aglatimagene besadenovec + valacyclovir

PrTK05

Phase 2 mab active

Quick answer

aglatimagene besadenovec + valacyclovir for Prostate Cancer Patients Treated by Radiotherapy is a Phase 2 program (mab) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Candel Therapeutics
Indication
Prostate Cancer Patients Treated by Radiotherapy
Phase
Phase 2
Modality
mab
Status
active

Clinical trials